Relationship between maternal experiences and adolescent HPV vaccination

ABSTRACT

The human papillomavirus (HPV) vaccine has been available for over a decade but its uptake rate is still low. To explore the relationship between the HPV vaccination status of a child and their mother's beliefs, behaviors and knowledge, we surveyed 1497 women with at least one child aged 9–17 y between September 2011 and November 2015. Physician recommendation was the most important factor associated with reported child vaccination status. Mothers who reported receiving a provider recommendation for the HPV vaccine were 32 times more likely to have a child who had been vaccinated compared with mothers who did not report provider recommendation (aOR) = 32.17; 95% CI: 21.77, 47.54). Knowing someone who had received the vaccine was also strongly associated with vaccination uptake (59% vs 12%, p < .001). Additionally, prior HPV diagnosis (aOR = 1.91; 95% CI: 1.18, 3.10) and knowing someone with cervical cancer (aOR = 1.38; 95% CI: 1.01, 1.89) were associated with child vaccination status. Mothers who perceived moderate to high risk for their child contracting HPV or developing genital warts or cervical cancer were more likely to report that their daughters (but not their sons) had been vaccinated.

KEYWORDS:

• adolescent
• human papillomavirus (HPV)
• HPV vaccine
• maternal
• physician recommendation
• vaccine uptake

Abbreviation

HPV

=

Human papillomavirus

Disclosure of potential conflicts of interest

The authors report no conflict of interest.

Acknowledgment

The authors thank Keitha Moseley-Dendy, MA of UTMB for her assistance with manuscript preparation.

Funding

Dr. Fuchs is supported by an institutional research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women's Health Program-BIRCWH; Berenson, PI) from the Office of Research on Women's Health (ORWH) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH). Dr. Fuchs and Dr. Brown worked on the project as postdoctoral fellows supported by an institutional training grant (National Research Service Award T32HD055163, Berenson, PI) from NIH/NICHD.

References

• Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans L, Curtis C, MacNeil J, Markowitz L, Singleton J. National, Regional, State, and Selected Local Area vaccination coverage among adolescents aged 13-17 years- United States, 2015. MMWR Morb Mortal Wkly Rep 2016; 65(33):850-8; PMID:27561081; https://doi.org/10.15585/mmwr.mm6533a4
   PubMed Web of Science ®Google Scholar
• DiClemente RJ, Murray CC, Graham T, Still J. Overcoming barriers to HPV vaccination: A randomized clinical trial of a culturally-tailored, media intervention among African American girls. Hum Vaccin Immunother 2015; 11(12):2883-94; PMID:26378650; https://doi.org/10.1080/21645515.2015.1070996
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Perez S, King L, Vivion M, Dubé E, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother 2015; 11(2):330-6; https://doi.org/10.4161/21645515.2014.980708
   PubMed Web of Science ®Google Scholar
• Grout RL, Beal SJ, Kahn JA, Widdice LE. Provider-level characteristics associated with adolescent varicella, meningococcal, and human papillomavirus immunization initiation. Clin Pediatr (Phila) 2016; 55(1):44-7; PMID:25963176; https://doi.org/10.1177/0009922815584215
   PubMed Web of Science ®Google Scholar
• Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006; 118:e1287-92; PMID:17079529; https://doi.org/10.1542/peds.2006-0923
   PubMed Web of Science ®Google Scholar
• Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011; 128(5):830-9; PMID:22007006; https://doi.org/10.1542/peds.2011-0950
   PubMed Web of Science ®Google Scholar
• Rahman M, Laz TH, McGrath CJ, Berenson AB. Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old US adolescent children. Clin Pediatr (Phila) 2015; 54(4):371-375; PMID:25238779; https://doi.org/10.1177/0009922814551135
   PubMed Web of Science ®Google Scholar
• Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 2011; 29(5):890-5
   PubMed Web of Science ®Google Scholar
• Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010; 126(3):425-33; PMID:20679306; https://doi.org/10.1542/peds.2009-3500
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Top 10 List for HPV #VaxSuccess. Atlanta: United States Department of Health & Human Services; 2017 Mar 10 [accessed 2017 Apr 20]. https://www.cdc.gov/hpv/downloads/top10-improving-practice.pdf
   Google Scholar
• Nelson EJ, Hughes J, Oakes JM, Pankow JS, Kulasingam SL. Geospatial patterns of human papillomavirus vaccine uptake in Minnesota. BMJ Open 2015; 5(8):e008617; PMID:26316652; https://doi.org/10.1136/bmjopen-2015-008617
   PubMed Web of Science ®Google Scholar
• Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013–2014. JAMA Oncol 2017; [epub ahead of print]; https://doi.org/10.1001/jamaoncol.2016.6192
   Web of Science ®Google Scholar